Home » Newsletters » BioWorld

BioWorld

April 5, 1994

View Archived Issues

CALGENE SEEKS USDA APPROVAL OF ITS CANOLA

T CELL SCIENCES, SMITHKLINE HALT CLINICAL TRIAL

AGRIDYNE HAS TWO PATENTS ALLOWED, GETS SBIR GRANT

JAPANESE FIRM LICENSES CHIRON RNA PROBE

LOOK-ALIKE AUTOIMMUNE ANTIBODIES BLOCK HIV

BIOTECHNOLOGY STOCK PERFORMANCE FOR FIRST QUARTER 1994

INTERNEURON'S STROKE DRUG BEGINS PHASE II/III TRIALS

ALKERMES BEGINS RMP-7 TRIALS

APPOINTMENTS AND ADVANCEMENTS

IMMUNEX FILES NEW SUPPLEMENTAL PLA FOR LEUKINE

TO OUR READERS

HEMOSOL FILES IND FOR RED BLOOD CELL SUBSTITUTE

NEORX'S INFRINGEMENT SUIT GOES ON

MAGAININ'S MSI-78 FOR IMPETIGO DEALT A SETBACK

TEACHING CELLS TO MAKE THEIR OWN ANTI-AIDS INTERFERON

GENEMEDICINE FILES FOR IPO

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 9, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
GDE4 blockade promotes remyelination, study finds
BioWorld Science
Myelin is crucial for the correct functioning of nerve signaling and its loss is a feature of neurological disorders. The cells responsible for myelination in the...